Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 October 2025 | Story Lacea Loader

The University of the Free State (UFS) Executive Committee (Exco), Institutional Representative Council (ISRC), and Campus Student Representative Councils (CSRCs) of the three campuses met on 15 October 2025 and reached an agreement regarding the implementation of the phasing out of provisional registration. 
The discussions were held in light of the decision made by the UFS Council on 26 September 2025 to phase out the provisional registration – a decision that led to the recent protest actions on the three campuses the past week. 

In a spirit of working towards a fairer, more equitable, and sustainable financial support system for all academically deserving students, Exco and the student leadership agreed that provisional registration will be phased out over a period of two years (2026-2027). This phased approach allows the university time to assess the risks students are facing with a view to assisting students. This means that from 1 January 2026, all students will be on a fully registered system. 

In recognition of the challenges students face, the outcomes of the meeting reflect the university’s ongoing commitment, and it ensures that all students are supported within a financially sustainable framework. It also reaffirms the university’s commitment to expanding access through enhanced financial support while sustaining the UFS as a national asset for future generations. 

The Exco remains committed to ongoing engagement with student leadership through open dialogue that reflects the university’s values, appreciates the constructive approach taken by the student leadership, and remains dedicated to working collaboratively in the best interest of all students and the broader university community.

News Archive

New Division of Virology to deliver crucial services for HIV diagnosis and resistance testing
2015-12-14

The establishment of a Division of Virology within the Department of Medical Microbiology, under the joint auspices of the UFS and the National Health Laboratory Service (NHLS), reflects the continued growth within Virology.  Dr Dominique Goedhals, Head of the Division, says the division will also provide training of undergraduate medical students, medical technologists and technicians, and registrars.

The newly established Division of Virology at the University of the Free State will be one of only five laboratories in the country to be involved in crucial diagnostic and testing services for HIV viral load monitoring, early infant diagnosis, and HIV resistance testing.

The Virology Diagnostic Laboratory serves as the reference laboratory for all HIV National Priority Programme samples for the Free State and Northern Cape provinces.

Medical staff at the laboratory will provide a 24-hour consultative service, as well as outreach programmes to district laboratories in the Free State and Northern Cape where pathologists are not available. 

Dr Dominique Goedhals, Head of the Division of Virology, says this division, under the joint auspices of the UFS and the National Health Laboratory Service (NHLS), reflects the continued growth within Virology.

The division will not only deliver this critical diagnostic service, but will also focus on training and teaching, as well as research.

Teaching and training activities include teaching of undergraduate medical students, medical technologists and technicians, and registrars.  The postgraduate science programme has a high output of honours, master’s and doctoral students in Virology.  The intern medical scientist programme is also active, with five interns having successfully submitted their portfolios since the programme was implemented in 2010.

Research activities under the Head of Research, Prof Felicity Burt, have also expanded and continue to show increases in publication output and acquisition of grant funding.  Established research groups within the Division of Virology focus on vector-borne and zoonotic viruses, human papilloma viruses (HPV), and human immunodeficiency virus (HIV), as well as work with a number of international collaborators.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept